• Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Dr. Pasi Janne talks about a new lung cancer study at ASCO 2012
  • 1:09
  • Pasi Jänne, MD, PhD, Dana-Farber Cancer Institute, talks about a new study being presented at ASCO 2012 involving a clinical trial that shows the success of targeted therapies in one of the most common forms of lung cancers. The results could mean a treatment or place to start for treatment concerning this type of lung cancer.

Tags: LungCancer, TargetedTherapy